Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Video game breathing: a new hope for Kids' lungs?

NCT ID NCT07765264

Disease control Sponsor: Delta University for Science and Technology Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Aug 14, 2026 · Last updated Aug 14, 2026

Summary

This trial tests whether a smartphone app that turns breathing exercises into interactive games can improve lung function in children aged 6 to 14 with chronic respiratory conditions like asthma. Participants will either use the gamified app or a standard plastic incentive spirometer for 12 weeks. The study measures changes in key lung function tests to see if the digital approach is more effective than traditional methods.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Digital-Gamified Diaphragmatic Training (DGDT) - an interactive mobile app that turns breathing exercises into games with real-time biofeedback.
What this could lead to
If effective, this could offer a more engaging and effective way for children to improve lung function and manage chronic respiratory conditions.
What could go wrong
The trial is relatively small and early-stage, and the benefits over standard care may not be significant. Adherence to the app could also be a challenge.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

170 people

The number who actually took part.

Started

Apr 2026

Expected to finish

Sep 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

6 to 14 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Pediatric patients aged 6 to 14 years at the time of screening. * Documented clinical diagnosis of a chronic respiratory condition (e.g., bronchial asthma, post-inflammatory pulmonary conditions), stable under standard pharmacological management for at least 4 consecutive weeks. * Household access to a functional smartphone (Android or iOS) capable of running mobile applications. * Written informed consent provided by a parent or legal guardian, and child's verbal or written assent. Exclusion Criteria: \- Occurrence of an acute pulmonary exacerbation, status asthmaticus, or respiratory tract infection requiring hospitalization within the last 30 days.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Chronic respiratory diseases are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

childhood onset asthma obstructive lung disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Chronic respiratory diseases Obstructive airway disease Pediatric asthma

Contacts and locations

Locations

  • Outpatient Pediatric Pulmonology Clinics, Damietta

    Damietta, 1234, Egypt

More trials for these conditions

Other studies related to the condition(s) this trial covers.